Qualigen Therapeutics (QLGN) Earnings Date & Reports

A.I. Advisor

published Earnings

QLGN is expected to report earnings to rise 45.00% to -14 cents per share on March 01

Qualigen Therapeutics QLGN Stock Earnings Reports

Q4'22

Est.

$-0.14

Q3'22

Beat

by $0.04

Q2'22

Beat

by $0.05

Q1'22

Beat

by $0.05

The last earnings report on November 15 showed earnings per share of -10 cents, beating the estimate of -14 cents. With 117.36K shares outstanding, the current market capitalization sits at 4.67M.

View a ticker or compare two or three

Compare

QLGN

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For QLGN
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a biotechnology company which focused on developing therapeutics for the treatment of cancer and infectious diseases

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

5857 Owens Avenue

Phone

+1 760 452-8111

Employees

Web

https://www.qlgntx.com